Palbociclib and Letrozole in HR-Positive Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors
Curr Probl Cancer 2022 Mar 28;46(3)100859, KE Gharib, W Macaron, J Kattan, MA Salloum, F Farhat, M Smith, FE KarakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.